Abstract:Forty-five structurally diverse 5-hydroxytryptamine(6) receptor (5-HT(6)R) antagonists were selected to develop a 3D pharmacophore model with the Catalyst software. The structural features for antagonism at this receptor are a positive ionizable atom interacting with Asp(3.32), a hydrogen bond acceptor group interacting with Ser(5.43) and Asn(6.55), a hydrophobic site interacting with residues in a hydrophobic pocket between transmembranes 3, 4, and 5, and an aromatic-ring hydrophobic site interacting with Phe… Show more
“…A 5-HT 6 antagonist pharmacophore has been previously described in the literature [7]. In our efforts to prepare potent and highly selective antagonists targeting 5-HT 6 based on this reported pharmacophore [8,9], we performed the synthesis of the title compound 1-[1-(4-chlorobenzenesulfonyl)-1H-indole-3-yl]-3-[4-(pyridin-2-yl)piperazin-1-yl]propan-1-one and evaluated its affinity for the 5-HT 6 receptor in a standard binding assay.…”
Abstract:The title compound was prepared by an aza-Michael addition reaction between 1-[1-(4-chlorobenzenesulfonyl)-1H-indole-3-yl]prop-2-en-1-one and 2-piridylpiperazine catalyzed by SiO 2 . The structural identity of the title compound was proven by elemental analysis and spectroscopic methods (IR, NMR). The compound was assayed in a binding assay at the 5-HT 6 receptor, showing poor affinity.
“…A 5-HT 6 antagonist pharmacophore has been previously described in the literature [7]. In our efforts to prepare potent and highly selective antagonists targeting 5-HT 6 based on this reported pharmacophore [8,9], we performed the synthesis of the title compound 1-[1-(4-chlorobenzenesulfonyl)-1H-indole-3-yl]-3-[4-(pyridin-2-yl)piperazin-1-yl]propan-1-one and evaluated its affinity for the 5-HT 6 receptor in a standard binding assay.…”
Abstract:The title compound was prepared by an aza-Michael addition reaction between 1-[1-(4-chlorobenzenesulfonyl)-1H-indole-3-yl]prop-2-en-1-one and 2-piridylpiperazine catalyzed by SiO 2 . The structural identity of the title compound was proven by elemental analysis and spectroscopic methods (IR, NMR). The compound was assayed in a binding assay at the 5-HT 6 receptor, showing poor affinity.
“…We wished to determine whether introduction of piperazinyl methyl group on N 1 -phenylsulfonyl moiety at C-3 0 position would have a desired effect on the binding to 5-HT 6 R and aimed to investigate the structure-activity relationship (SAR). Researchers have developed a pharmacophore model ( Figure 3) for 5-HT 6 receptor antagonists, based on reported chemically diverse 5-HT 6 receptor antagonists [35][36][37][38][39][40][41][42]34 . In this pharmacophore model, four core features were taken into consideration which include the positive ionizable atom (PI, usually a secondary or tertiary amino group), a hydrogen bond acceptor group (HBA, usually a sulfone or sulfonamide group), a hydrophobic site (HYD) and -electron donor aromatic or heterocyclic ring (AR).…”
A series of 1-[3-(4-methyl piperazin-1-ylmethyl) phenylsulfonyl]-1H-indole and 1-[3-(4-ethyl piperazin-1-ylmethyl) phenylsulfonyl]-1H-indole derivatives were designed and synthesized as 5-HT 6 receptor (5-HT 6 R) ligands. The lead compound 1-[4-methyl-3-(4-methyl piperazin-1-yl methyl) phenylsulfonyl]-1H-indole dihydrochloride (6b), in this series, has shown potent in vitro binding affinity, selectivity, good pharmacokinetics (PK) profile and activity in the animal models of cognition.
“…Since then a lot of reports have been published regarding variations in N,N-dimethyl amino alkyl side chain on and around the indole nucleus and their affinity 21,32,33 ( Figure 2). Numerous selective antagonists of 5-HT 6 receptors have been disclosed during the last decade [34][35][36][37][38][39][40][41][42] and a pharmacophore model for this type of receptor antagonists has been developed based on known structurally diverse 5-HT 6 receptor antagonists [43][44][45][46][47][48][49] . In general, the model entails the positive ionizable atom (usually a secondary or tertiary amino group), a hydrogen bond acceptor group (usually a sulfone or sulfonamide group), a hydrophobic site (HYD) and -electron donor aromatic or heterocyclic ring (AR).…”
A series of N 0 -[3-(indole-1-sulfonyl) aryl]-N,N-dimethyl ethane-1,2-diamines and N 0 -[3-(indole-1-sulfonyl) aryl]-N,N-dimethyl propane-1,3-diamines was designed and synthesized as 5-HT 6 receptor ligands. These compounds, when screened in a functional reporter gene-based assay, displayed potent antagonistic activity with K b values in the range of 1.8-60 nM. The lead compound 9y has shown good ADME surrogate properties, acceptable pharmacokinetic profile and is active in animal models of cognition like novel object recognition test and Morris water maze. It was selected for detailed profiling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.